The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project

This commentary describes the progress of the SEAL [Surrogate Endpoints for Aggressive Lymphoma] research group and invites collaboration in sharing data to continue building a large database of individual patient data from multiple clinical trials in DLBCL.

Detalles Bibliográficos
Autores principales: Sargent, Daniel J., Shi, Qian, Flowers, Christopher R., Schmitz, Norbert, Habermann, Thomas M., Flament, Jocelyne, Fu, Tommy, Coiffier, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728027/
https://www.ncbi.nlm.nih.gov/pubmed/28798271
http://dx.doi.org/10.1634/theoncologist.2017-0177
Descripción
Sumario:This commentary describes the progress of the SEAL [Surrogate Endpoints for Aggressive Lymphoma] research group and invites collaboration in sharing data to continue building a large database of individual patient data from multiple clinical trials in DLBCL.

Ejemplares similares